Web Results



Lomustine (INN), abbreviated CCNU is an alkylating nitrosourea compound used in chemotherapy. It is closely related to semustine and is in the same family as ...

Lomustine (CCNU): Indications, Side Effects, Warnings - Drugs.com


Lomustine (CCNU) is usually taken as a single dose only once every 6 weeks. Do NOT take a dose of lomustine (CCNU) more than once within a 6-week period  ...

Lomustine: MedlinePlus Drug Information


Mar 15, 2016 ... Lomustine can cause a severe decrease in the number of blood cells in your bone marrow. A decrease in the number of blood cells in your ...

Lomustine (CCNU) | Cancer Research UK


Apr 28, 2015 ... Read about the cancer treatment drug lomustine, otherwise known as CCNU, including what it is, how it works and possible side effects.

CeeNu (lomustine) - U.S. Food and Drug Administration


(lomustine). Capsules. WARNINGS. CeeNU (lomustine) should be administered under the supervision of a qualified physician experienced in the use of cancer ...

lomustine | C9H16ClN3O2 - PubChem


Lomustine is a nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis. This agent also ...

lomustine oral : Uses, Side Effects, Interactions, Pictures, Warnings ...


Find patient medical information for lomustine oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Lomustine (Oral Route) Description and Brand Names - Mayo Clinic


Dec 1, 2015 ... Lomustine is used alone or in combination with other medicines to treat brain tumors, Hodgkin's disease, and other kinds of cancer.

Lomustine (CeeNU®, CCNU) | Oncolink - Cancer Resources


Jan 6, 2016 ... Lomustine is an alkylating agent used in the treatment of brain tumors and Hodgkin's disease.

DrugBank: Lomustine


Name, Lomustine. Accession Number, DB01206 (APRD00292). Type, Small Molecule. Groups, Approved. Description. An alkylating agent of value against both ...

More Info

Lomustine - Chemotherapy Drugs - Chemocare


Drug type: Lomustine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "alkylating agent." (For more detail ...

Lomustine - National Cancer Institute


Feb 27, 2012 ... This page contains brief information about lomustine and a collection of links to more information about the use of this drug, research results, ...

CeeNU (Lomustine Capsules): Side Effects, Interactions, Warning ...


WARNING. CeeNU (lomustine) should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic ...